China Merchants Bank Co Ltd top stories

• CMBI hires from China Renaissance for ECM head

  

  CMB International has hired Branson Song, a veteran equity capital markets banker, as head of its ECM business.

  • 21 Jul 2021

• Chinese property companies push sustainability market further

  Three Chinese real estate developers sold green and sustainable bonds on Monday, adding further momentum to the booming asset class.

  • 20 Jul 2021

• Didi boosts IPO to $4.4bn with top end pricing

  Chinese ride-hailing giant Didi has raised $4.4bn from its New York Stock Exchange IPO, increasing the size of the float after investors pumped more than $40bn of orders into the book.

  • 30 Jun 2021

• Missfresh's US shares tumble on debut trading

  Chinese online grocer Missfresh saw its share price sink on its trading debut, after it priced its Nasdaq IPO at the bottom of the marketed range.

  • 28 Jun 2021

• Didi hits the road with US IPO, targets $67bn valuation

  Chinese ride-hailing firm Didi Chuxing has launched its New York Stock Exchange IPO, aiming to raise $4.03bn from the largest China-into-US listing since Alibaba Group Holding’s jumbo $25bn deal in 2014.

  • 25 Jun 2021

• Hong Kong’s HutchMed nets $537m from third IPO

  Biopharmaceutical company HutchMed (China) pocketed HK$4.17bn ($537.1m) this week from its Hong Kong IPO.

  • 24 Jun 2021

• China’s Dingdong, Missfresh vie for investor attention

  Dingdong (Cayman), a Chinese e-commerce company for fresh groceries, and its rival Missfresh are testing investor appetite at the same time for their US IPOs.

  • 23 Jun 2021

• LBO loans: Chinese banks step up

  The recent round of M&A and leveraged buyout financing provided by Chinese banks shows their growing ambition in the more complicated and riskier part of Asia’s loan market.

  • 22 Jun 2021

• 51job raises $1.8bn loan for privatisation

  Chinese online human resources service provider 51job has raised a $1.825bn term loan from two banks to support its take-private.

  • 22 Jun 2021

• Zylox-Tonbridge rolls out $330m Hong Kong float

  Zylox-Tonbridge Medical Technology, a China-based medical device maker, is looking to raise up to HK$2.56bn ($329.9m) from a Hong Kong IPO.

  • 22 Jun 2021